The global pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) virus has revealed the urgent need for accurate, rapid, and affordable
diagnostic tests for epidemic understanding and management by monitoring the population
worldwide. Though current diagnostic methods including real-time polymerase chain
reaction (RT-PCR) provide sensitive detection of SARS-CoV-2, they require relatively
long processing time, equipped laboratory facilities, and highly skilled personnel.
Laser-scribed graphene (LSG)-based biosensing platforms have gained enormous attention
as miniaturized electrochemical systems, holding an enormous potential as point-of-care
(POC) diagnostic tools. We describe here a miniaturized LSG-based electrochemical
sensing scheme for coronavirus disease 2019 (COVID-19) diagnosis combined with
three-dimensional (3D) gold nanostructures. This electrode was modified with the
SARS-CoV-2 spike protein antibody following the proper surface modifications proved by
X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy (SEM)
characterizations as well as electrochemical techniques. The system was integrated into
a handheld POC detection system operated using a custom smartphone application,
providing a user-friendly diagnostic platform due to its ease of operation,
accessibility, and systematic data management. The analytical features of the
electrochemical immunoassay were evaluated using the standard solution of S-protein in
the range of 5.0–500 ng/mL with a detection limit of 2.9 ng/mL. A clinical study
was carried out on 23 patient blood serum samples with successful COVID-19 diagnosis,
compared to the commercial RT-PCR, antibody blood test, and enzyme-linked immunosorbent
assay (ELISA) IgG and IgA test results. Our test provides faster results compared to
commercial diagnostic tools and offers a promising alternative solution for
next-generation POC applications.
Point of care (PoC) devices are highly demanding to control current pandemic, originated from severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Though nucleic acid-based methods such as RT-PCR are widely available, they require sample preparation and long processing time. PoC diagnostic devices provide relatively faster and stable results. However they require further investigation to provide high accuracy and be adaptable for the new variants. In this study, laser-scribed graphene (LSG) sensors are coupled with gold nanoparticles (AuNPs) as stable promising biosensing platforms. Angiotensin Converting Enzyme 2 (ACE2), an enzymatic receptor, is chosen to be the biorecognition unit due to its high binding affinity towards spike proteins as a key-lock model. The sensor was integrated to a homemade and portable potentistat device, wirelessly connected to a smartphone having a customized application for easy operation. LODs of 5.14 and 2.09 ng/mL was achieved for S1 and S2 protein in the linear range of 1.0–200 ng/mL, respectively. Clinical study has been conducted with nasopharyngeal swabs from 63 patients having alpha (B.1.1.7), beta (B.1.351), delta (B.1.617.2) variants, patients without mutation and negative patients. A machine learning model was developed with accuracy of 99.37% for the identification of the SARS-Cov-2 variants under 1 min. With the increasing need for rapid and improved disease diagnosis and monitoring, the PoC platform proved its potential for real time monitoring by providing accurate and fast variant identification without any expertise and pre sample preparation, which is exactly what societies need in this time of pandemic.
Syphilis is a health problem of increasing incidence in recent years that may have severe complications if not diagnosed and treated at an early stage. There are many diagnostic tests available for syphilis, but there is no gold standard, and diagnosis therefore usually relies upon a combination of tests. In this multicenter study, we evaluated the treponemal Elecsys syphilis assay for use in the diagnosis of syphilis in routine samples, i.e., when syphilis is suspected or during antenatal or blood donation screening. The sensitivity and specificity of the Elecsys syphilis assay were compared head to head with those of other treponemal assays used in routine clinical practice and were assessed in potentially cross-reactive samples from patients with Epstein-Barr virus, HIV, and Lyme disease. In a total of 8,063 syphilis-negative samples collected from routine diagnostic requests and blood donations, the Elecsys syphilis assay had a specificity of 99.88%. In 928 samples previously identified as syphilis positive, the sensitivity was 99.57 to 100% (the result is presented as a range depending on whether four initially indeterminate samples are included in the assessment). The specificity of the Elecsys syphilis assay in patients with other infections was 100%; no false-positive samples were identified.
The aim of this study was to compare direct sequence analysis of partial HBV pol gene and Inno-LiPA HBV DR in serum samples of 120 chronic hepatitis B patients sent to the Clinical Microbiology Laboratory of Ege University Hospital because of lamivudine resistance. Sequence analysis was performed on ABI Prism 310 Genetic Analyzer. Comparison of Inno-LiPA and sequence results obtained by double-blind evaluation showed full agreement (both at rt180 and rt204) in 58.8% of samples. Visually rechecking of the electropherograms increased this rate to 68.3% Codon based rates are 81.7% and 75.8% at rt180 and rt204 respectively. LiPA detected variants in additional 12 (10%) samples, but missed one variant sample (both rt180 and rt204) and one sample was indeterminate due to poor probe binding. LiPA allows determination of mixed variants and seems to be more sensitive and simple for routine testing even though sequence analysis is still the gold standard for detecting new variants.
HDV genotyping was successfully performed by direct sequencing of the amplicons obtained from routine HDV-RNA screening PCR tests. All of the HDV isolates from the chronic delta hepatitis patients included in this study were found to be genotype I.
Girifl ve Amaç: Bu çal›flman›n amac›, bölgemizde, hepatit C virüsü infeksiyonunun olas› bulafl›m yollar›n›n ve yak›n dönemde hepatit C virüsü genotiplerinin da¤›l›m›n›n belirlenmesidir. Gereç ve Yöntem: Hepatit C virüsü risklerinin belirlenmesi amac› ile Ege Üniversitesi Hastanesi T›bbi Mikrobiyoloji Laboratuvar›na, 2005-2010
The global pandemic of COVID-19 continues to be an important threat, especially with
the fast transmission rate observed after the discovery of novel mutations. In this
perspective, prompt diagnosis requires massive economical and human resources to
mitigate the disease. The current study proposes a rational design of a colorimetric
lateral flow immunoassay (LFA) based on the repurposing of human samples to produce
COVID-19-specific antigens and antibodies in combination with a novel dye-loaded
polymersome for naked-eye detection. A group of 121 human samples (61 serums and 60
nasal swabs) were obtained and analyzed by RT-PCR and ELISA. Pooled samples were used to
purify antibodies using affinity chromatography, while antigens were purified
via
magnetic nanoparticles-based affinity. The purified proteins were
confirmed for their specificity to COVID-19
via
commercial LFA, ELISA,
and electrochemical tests in addition to sodium dodecyl sulfate-polyacrylamide gel
electrophoresis analysis. Polymersomes were prepared using methoxy polyethylene
glycol-
b
-polycaprolactone (mPEG-
b
-PCL) diblock
copolymers and loaded with a Coomassie Blue dye. The polymersomes were then
functionalized with the purified antibodies and applied for the preparation of two types
of LFA (antigen test and antibody test). Overall, the proposed diagnostic tests
demonstrated 93 and 92.2% sensitivity for antigen and antibody tests, respectively. The
repeatability (92–94%) and reproducibility (96–98%) of the tests highlight
the potential of the proposed LFA. The LFA test was also analyzed for stability, and
after 4 weeks, 91–97% correct diagnosis was observed. The current LFA platform is
a valuable assay that has great economical and analytical potential for widespread
applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.